This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2004 May;2(5):376-8.

doi: 10.1016/s1542-3565(04)00121-1.

5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion

PMID: 15118974
DOI: 10.1016/s1542-3565(04)00121-1

Editorial

5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion

Brian G Feagan. Clin Gastroenterol Hepatol. 2004 May.

. 2004 May;2(5):376-8.

doi: 10.1016/s1542-3565(04)00121-1.

Author

PMID: 15118974
DOI: 10.1016/s1542-3565(04)00121-1

No abstract available

PubMed Disclaimer

Comment on

Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.
Hanauer SB, Strömberg U. Hanauer SB, et al. Clin Gastroenterol Hepatol. 2004 May;2(5):379-88. doi: 10.1016/s1542-3565(04)00122-3. Clin Gastroenterol Hepatol. 2004. PMID: 15118975

Similar articles

Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG. Feagan BG. Eur J Surg. 1998 Dec;164(12):903-9. doi: 10.1080/110241598750005066. Eur J Surg. 1998. PMID: 10029385 Review. No abstract available.
Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
Rutgeerts P. Rutgeerts P. Gut. 2001 Apr;48(4):452-3. doi: 10.1136/gut.48.4.452. Gut. 2001. PMID: 11247886 Free PMC article. No abstract available.
Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
Kamm MA. Kamm MA. Inflamm Bowel Dis. 2005 Jun;11(6):616-7. doi: 10.1097/01.mib.0000160744.32396.02. Inflamm Bowel Dis. 2005. PMID: 15905712
The case for using 5-aminosalicyclates in Crohn's disease: pro.
Hanauer SB. Hanauer SB. Inflamm Bowel Dis. 2005 Jun;11(6):609-12. doi: 10.1097/01.mib.0000160743.24772.69. Inflamm Bowel Dis. 2005. PMID: 15905710
Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG, Sandborn WJ. Feagan BG, et al. Rev Gastroenterol Disord. 2002;2 Suppl 2:S9-15. Rev Gastroenterol Disord. 2002. PMID: 12478239 Review.

See all similar articles

Cited by

Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.
Łodyga M, Eder P, Gawron-Kiszka M, Dobrowolska A, Gonciarz M, Hartleb M, Kłopocka M, Małecka-Wojciesko E, Radwan P, Reguła J, Zagórowicz E, Rydzewska G. Łodyga M, et al. Prz Gastroenterol. 2021;16(4):257-296. doi: 10.5114/pg.2021.110914. Epub 2021 Nov 19. Prz Gastroenterol. 2021. PMID: 34976235 Free PMC article.
Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC, Wang Y, MacDonald JK, Hanauer S. Lim WC, et al. Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2. Cochrane Database Syst Rev. 2016. PMID: 27372735 Free PMC article.
European evidence based consensus on the diagnosis and management of Crohn's disease: current management.
Travis SP, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ; European Crohn's and Colitis Organisation. Travis SP, et al. Gut. 2006 Mar;55 Suppl 1(Suppl 1):i16-35. doi: 10.1136/gut.2005.081950b. Gut. 2006. PMID: 16481629 Free PMC article.
Guidelines for the management of inflammatory bowel disease in adults.
Carter MJ, Lobo AJ, Travis SP; IBD Section, British Society of Gastroenterology. Carter MJ, et al. Gut. 2004 Sep;53 Suppl 5(Suppl 5):V1-16. doi: 10.1136/gut.2004.043372. Gut. 2004. PMID: 15306569 Free PMC article. No abstract available.
Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease.
Gölder SK, Schreyer AG, Endlicher E, Feuerbach S, Schölmerich J, Kullmann F, Seitz J, Rogler G, Herfarth H. Gölder SK, et al. Int J Colorectal Dis. 2006 Mar;21(2):97-104. doi: 10.1007/s00384-005-0755-0. Epub 2005 Apr 22. Int J Colorectal Dis. 2006. PMID: 15846497

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information